Literature DB >> 12383538

Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia.

Scott Kauma1, Peter Takacs, Constantine Scordalakes, Scott Walsh, Kermic Green, Thomas Peng.   

Abstract

OBJECTIVE: To test the hypothesis that preeclampsia is associated with increased endothelial cell chemokine production of monocyte chemoattractant protein-1 and interleukin-8 necessary for monocyte recruitment to the vascular endothelium.
METHODS: Plasma was collected from women with severe preeclampsia and normal pregnant women at term and measured for monocyte chemoattractant protein-1, interleukin-8, and lipid peroxide levels by enzyme-linked immunosorbent assays and malondialdehyde assays. Human umbilical vein endothelial cells were cultured with 5% plasma from normal or preeclamptic patients and the media assayed for monocyte chemoattractant protein-1 and interleukin-8 production.
RESULTS: In women with severe preeclampsia, plasma levels of monocyte chemoattractant protein-1, interleukin-8, and lipid peroxides were elevated (1.5-fold, 2.5-fold, and 4.5-fold higher, respectively) compared with normal pregnant women. Human umbilical vein endothelial cells cultured with plasma from preeclamptic women significantly increased the production of both monocyte chemoattractant protein-1 (2.3-fold) and interleukin-8 (1.5-fold) compared with plasma from normal pregnant women. Monocyte chemoattractant protein-1 and interleukin-8 production was decreased by the antioxidant vitamin E in human umbilical vein endothelial cells treated with preeclamptic plasma, suggesting that the production of these cytokines may be regulated by signaling mechanisms sensitive to oxidative stress.
CONCLUSION: These findings support the hypothesis that circulating factors in the plasma of women with preeclampsia activate endothelial cell monocyte chemoattractant protein-1 and interleukin-8 production, and although not directly examined in this study, may increase monocyte adherence to the vascular endothelium.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383538     DOI: 10.1016/s0029-7844(02)02169-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  19 in total

Review 1.  In utero oxidative stress epigenetically programs antioxidant defense capacity and adulthood diseases.

Authors:  Rita S Strakovsky; Yuan-Xiang Pan
Journal:  Antioxid Redox Signal       Date:  2012-01-11       Impact factor: 8.401

2.  Elevated plasma levels of interleukin 1 beta, tumour necrosis factor alpha and monocyte chemotactic protein 1 are associated with pregnancy toxaemia in ewes.

Authors:  G F Yarim; S Karahan; C Nisbet
Journal:  Vet Res Commun       Date:  2007-01-13       Impact factor: 2.459

3.  Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.

Authors:  Meghan H Pearl; Qiuheng Zhang; Miguel Fernando Palma Diaz; Jonathan Grotts; Maura Rossetti; David Elashoff; David W Gjertson; Patricia Weng; Elaine F Reed; Eileen Tsai Chambers
Journal:  Kidney Int       Date:  2017-09-18       Impact factor: 10.612

4.  Neutrophil expression of cyclooxygenase 2 in preeclampsia.

Authors:  Teddi Bachawaty; Sonya L Washington; Scott W Walsh
Journal:  Reprod Sci       Date:  2010-03-10       Impact factor: 3.060

5.  Enoxaparin Increases D6 Receptor Expression and Restores Cytoskeleton Organization in Trophoblast Cells from Preeclampsia.

Authors:  Chiara Tersigni; Giuseppe Maulucci; Roberta Castellani; Giada Bianchetti; Marianna Onori; Rita Franco; Greta Barbaro; Marco De Spirito; Antonio Lanzone; Giovanni Scambia; Nicoletta Di Simone
Journal:  Cells       Date:  2022-06-27       Impact factor: 7.666

6.  Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy.

Authors:  Snježana Kaštelan; Martina Tomić; Josip Pavan; Slavko Orešković
Journal:  Reprod Biol Endocrinol       Date:  2010-10-21       Impact factor: 5.211

7.  Leukocytes of pregnant women with small-for-gestational age neonates have a different phenotypic and metabolic activity from those of women with preeclampsia.

Authors:  Giovanna Oggé; Roberto Romero; Tinnakorn Chaiworapongsa; Maria Teresa Gervasi; Percy Pacora; Offer Erez; Juan Pedro Kusanovic; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Pooja Mittal; Yeon Mee Kim; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-06

Review 8.  An unexpected tail of VEGF and PlGF in pre-eclampsia.

Authors:  David O Bates
Journal:  Biochem Soc Trans       Date:  2011-12       Impact factor: 5.407

Review 9.  Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.

Authors:  Corinne Rusterholz; Sinuhe Hahn; Wolfgang Holzgreve
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

10.  Expression levels of seven candidate genes in human peripheral blood mononuclear cells and their association with preeclampsia.

Authors:  M L Martinez-Fierro; I Garza-Veloz; K Carrillo-Sanchez; V Martinez-Gaytan; R Cortes-Flores; M A Ochoa-Torres; G G Guerrero; I P Rodriguez-Sanchez; C O Cancela-Murrieta; M Zamudio-Osuna; J I Badillo-Almaraz; C Castruita-De la Rosa
Journal:  Hypertens Pregnancy       Date:  2013-12-02       Impact factor: 2.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.